These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17058097)

  • 1. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey.
    Ghofrani M; Tapia B; Tavassoli FA
    Virchows Arch; 2006 Dec; 449(6):609-16. PubMed ID: 17058097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
    Sneige N; Staerkel GA
    Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
    Goldstein NS; O'Malley BA
    Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
    Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 1999 Nov; 23(11):1340-8. PubMed ID: 10555002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.
    Tavassoli FA
    Mod Pathol; 1998 Feb; 11(2):140-54. PubMed ID: 9504685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
    Böcker W; Decker T; Ruhnke M; Schneider W
    Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast papillomas with atypical ductal hyperplasia: a clinicopathologic study.
    Raju U; Vertes D
    Hum Pathol; 1996 Nov; 27(11):1231-8. PubMed ID: 8912836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.
    Lennington WJ; Jensen RA; Dalton LW; Page DL
    Cancer; 1994 Jan; 73(1):118-24. PubMed ID: 8275415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.
    Moore MM; Hargett CW; Hanks JB; Fajardo LL; Harvey JA; Frierson HF; Slingluff CL
    Ann Surg; 1997 Jun; 225(6):726-31; discussion 731-3. PubMed ID: 9230813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications.
    Fraser JL; Raza S; Chorny K; Connolly JL; Schnitt SJ
    Am J Surg Pathol; 1998 Dec; 22(12):1521-7. PubMed ID: 9850178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypia in breast pathology: what pathologists need to know.
    Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
    Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
    Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Gomes DS; Porto SS; Balabram D; Gobbi H
    Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.
    Goldstein NS; Lacerna M; Vicini F
    Am J Clin Pathol; 1998 Sep; 110(3):357-67. PubMed ID: 9728611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
    Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
    J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.